在第二阶段结肠癌中瘤芽的免疫组织化学分析:探索零芽作为预后标志物
Maria Pihlmann Kristensen1,2,3, Ulrik Korsgaard4,5,6,7, Signe Timm5,6,8
1Department of Pathology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark. maria.pihlmann.kristensen@rsyd.dk.
概括
全细胞克拉丁免疫组织化学 (IHC) 提高了II期结肠癌瘤芽的预后准确性. 使用IHC的瘤芽缺失 (Bd0) 预测没有复发,为患者分层提供了宝贵的见解.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 癌症生物标志物 癌症生物标志物
背景情况:
- 瘤芽是第二阶段结肠癌的预后生物标志物,传统上通过H&E染色来评估.
- 由于H&E染色的局限性,需要先进的技术,例如泛细胞克拉免疫组织化学 (IHC).
研究的目的:
- 评估使用IHC在II期结肠癌患者当代队列中芽瘤的预后意义.
- 为了比较基于IHC的瘤芽评估与传统的H&E染色.
主要方法:
- 对493名II期结肠癌患者进行了以后视的,基于人群的队列研究.
- 使用IHC评估瘤芽,遵循国际瘤芽共识会议的指导方针.
- 评估了H&E和IHC芽之间的相关性;进行了生存分析.
主要成果:
- IHC产生的芽数量明显高于H&E (p < 0.01).
- 没有IHC的瘤芽 (Bd0) 与明显改善的无复发生存率 (HR=5.19,p=0.02) 和整体生存率 (HR=4.47,p=0.04) 相关.
- Bd0类别显示了100%的预测值,即没有复发.
结论:
- 基于IHC的瘤芽评估为II期结肠癌提供了额外的预后信息.
- 没有IHC的瘤芽 (Bd0) 表示有利的预后.
- 基于IHC的瘤芽可以识别没有复发风险的患者.
更多相关视频
06:05Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
Published on: June 2, 2023
7.4K
06:32Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
Published on: August 18, 2023
2.0K
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...